Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRAH | Common Stock | Options Exercise | $908K | +77.4K | +141.74% | $11.73 | 132K | Jun 17, 2021 | Direct | |
transaction | PRAH | Common Stock | Options Exercise | $1.95M | +166K | +125.74% | $11.73 | 298K | Jun 17, 2021 | Direct | |
transaction | PRAH | Common Stock | Options Exercise | $6.9M | +91K | +30.53% | $75.81 | 389K | Jun 17, 2021 | Direct | |
transaction | PRAH | Common Stock | Options Exercise | $2.97M | +31K | +7.97% | $95.94 | 420K | Jun 17, 2021 | Direct | |
transaction | PRAH | Common Stock | Options Exercise | $4.61M | +45K | +10.71% | $102.44 | 465K | Jun 17, 2021 | Direct | |
transaction | PRAH | Common Stock | Options Exercise | $3.28M | +31.8K | +6.83% | $103.30 | 497K | Jun 17, 2021 | Direct | |
transaction | PRAH | Common Stock | Sale | -$154K | -920 | -0.19% | $166.89 | 496K | Jun 17, 2021 | Direct | F1, F2 |
transaction | PRAH | Common Stock | Sale | -$27.1M | -161K | -32.53% | $168.13 | 335K | Jun 17, 2021 | Direct | F1, F3 |
transaction | PRAH | Common Stock | Sale | -$37.2M | -220K | -65.81% | $169.00 | 114K | Jun 17, 2021 | Direct | F1, F4 |
transaction | PRAH | Common Stock | Sale | -$10.1M | -59.8K | -52.25% | $169.63 | 54.6K | Jun 17, 2021 | Direct | F1, F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRAH | Stock Option (Right to Buy) | Options Exercise | $0 | -77.4K | -100% | $0.00* | 0 | Jun 17, 2021 | Common Stock | 77.4K | $11.73 | Direct | |
transaction | PRAH | Stock Option (Right to Buy) | Options Exercise | $0 | -166K | -100% | $0.00* | 0 | Jun 17, 2021 | Common Stock | 166K | $11.73 | Direct | F6 |
transaction | PRAH | Stock Option (Right to Buy) | Options Exercise | $0 | -91K | -70% | $0.00 | 39K | Jun 17, 2021 | Common Stock | 91K | $75.81 | Direct | F7 |
transaction | PRAH | Stock Option (Right to Buy) | Options Exercise | $0 | -31K | -33.33% | $0.00 | 62K | Jun 17, 2021 | Common Stock | 31K | $95.94 | Direct | F8 |
transaction | PRAH | Stock Option (Right to Buy) | Options Exercise | $0 | -45K | -50% | $0.00 | 45K | Jun 17, 2021 | Common Stock | 45K | $102.44 | Direct | F9 |
transaction | PRAH | Stock Option (Right to Buy) | Options Exercise | $0 | -31.8K | -33.33% | $0.00 | 63.6K | Jun 17, 2021 | Common Stock | 31.8K | $103.30 | Direct | F10 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.43 to $167.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.53 to $168.525, inclusive. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.53 to $169.52, inclusive. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.53 to $169.87, inclusive. |
F6 | The option vested in five equal annual installments, commencing on September 23, 2014 |
F7 | The option vests in four annual installments, commencing on August 29, 2018 at 20% of the grant in the first two years and 30% of the grant in the remaining two years thereafter. |
F8 | The option vests in three equal annual installments of 31,000 beginning on August 13, 2020. |
F9 | The option vests in four equal annual installments of 22,500 beginning on August 16, 2019. |
F10 | The option vests in three equal annual installments of 31,780 beginning on June 1, 2021. |